Description
SYN-AKE 10MG
10mg | Laboratory Research Grade
Strictly for Research Purposes – Not for Human Consumption
SYN-AKE (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is a synthetic tripeptide derivative modeled after Waglerin 1, a neuromuscular blocking peptide found in the venom of the Temple Viper (Tropidolaemus wagleri). In laboratory in vitro research, SYN-AKE is studied for its ability to target post-synaptic membrane receptors, inhibiting muscle nicotinic acetylcholine receptors (mnAChR) to modulate neuromuscular signaling pathways and expression line formation dynamics.
Product Technical Specifications
| Feature | Specification |
|---|---|
| Compound | SYN-AKE 10mg |
| Sequence | β-Alanine – L-Proline – Diaminobutyric Acid – Benzylamide |
| Molecular Formula | C₂₃H₃₇N₅O₇ |
| Molecular Weight | 495.58 g/mol |
| Analytical Purity | > 98% (HPLC Certified) |
| Format | Lyophilized Powder (Vacuum Stabilized) |
| Quantity | 10 mg per vial |
| Storage | -20°C (Dry) / 2–8°C (Reconstituted) |
| Grade | Laboratory Research Grade |
SYN-AKE 10mg Research Application Areas
Current laboratory studies on SYN-AKE 10mg focus on the following key research areas:
- Nicotinic Acetylcholine Receptor Antagonism: Evaluation of post-synaptic blockage mechanisms at muscle nicotinic receptors (mnAChR).
- Neuromuscular Signaling Modulation: Study of peptide influence on signal attenuation across cellular junction models.
- Dermal Smoothing & Expression Line Metrics: In vitro research into topical and cellular dynamics affecting surface tension and tissue relaxation.
- Comparative Peptide Efficiency: Performance benchmarking against Acetyl Hexapeptide-8 and other peptide-based neurotransmitter inhibitors.
Looking for another SYN-AKE 10mg alternative? Explore our full range of Research Peptides.
⚠️ MANDATORY LEGAL DISCLAIMER: THIS PRODUCT IS NOT INTENDED FOR HUMAN CONSUMPTION. IT IS SOLD EXCLUSIVELY FOR LABORATORY USE AND RESEARCH PURPOSES.
